Prospective, single-centre study with the central question of how the metabolome from blood samples, different body fluids and tissues between patients patients with malignant melanoma in different tumour tumour stages and healthy patients and whether this is suitable for early detection of initial diagnosis, recurrence or stage shift at an early stage.
The biosamples are collected in the BioBank Dresden and used for the NMR and LC-MS analyses described here. It is planned to use the biosamples for further analyses.
Current or past history of melanoma
Ongoing therapy or tumour aftercare at the Skin Cancer Centre at Dresden University Hospital
Refusal to participate in the study
Lack of capacity to consent
Patients receiving ongoing tumour therapy or tumour aftercare at the Skin Cancer Centre at Dresden University Hospital
Cohort
Prospective
Not listed
Differences in metabolite concentrations
Metabolite concentrations are measured by NMR spectroscopy and gas chromatography and compared between different subgroups.
Click on the lead sponsor to view all of their trials.
Technische Universität Dresden
Lead sponsor
University Hospital Carl Gustav Carus
Sponsor institution
University Hospital Carl Gustav Carus
Collaborator
